GoHealth, Inc. (NASDAQ:GOCO) Receives $15.60 Average Price Target from Analysts

Shares of GoHealth, Inc. (NASDAQ:GOCO) have been given a consensus rating of “Buy” by the eight brokerages that are presently covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month target price among brokers that have covered the stock in the last year is $15.60.

GOCO has been the subject of a number of recent analyst reports. Barclays dropped their price target on GoHealth from $18.00 to $10.00 and set an “overweight” rating for the company in a report on Friday, August 13th. Raymond James cut GoHealth from an “outperform” rating to a “market perform” rating in a research note on Thursday, August 12th. Zacks Investment Research cut GoHealth from a “buy” rating to a “hold” rating in a research note on Thursday, August 12th. Credit Suisse Group cut GoHealth from an “outperform” rating to a “neutral” rating and lowered their target price for the company from $18.00 to $10.00 in a research note on Thursday, August 12th. Finally, Morgan Stanley lowered their target price on GoHealth from $14.00 to $13.00 and set an “equal weight” rating for the company in a research note on Thursday, August 12th.

GOCO stock traded up $0.13 during midday trading on Friday, reaching $5.39. 70,686 shares of the company’s stock traded hands, compared to its average volume of 2,866,461. The company has a 50-day simple moving average of $5.45 and a two-hundred day simple moving average of $9.13. GoHealth has a 1-year low of $4.00 and a 1-year high of $16.37. The company has a market cap of $1.73 billion, a price-to-earnings ratio of -14.24 and a beta of 0.08. The company has a quick ratio of 2.60, a current ratio of 2.60 and a debt-to-equity ratio of 0.46.

GoHealth (NASDAQ:GOCO) last released its quarterly earnings results on Wednesday, August 11th. The company reported ($0.12) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.05) by ($0.07). GoHealth had a negative net margin of 3.42% and a positive return on equity of 13.28%. The business had revenue of $196.90 million for the quarter, compared to analyst estimates of $174.09 million. Equities research analysts forecast that GoHealth will post 0.65 EPS for the current year.

In other GoHealth news, CEO Clinton P. Jones bought 24,210 shares of GoHealth stock in a transaction on Wednesday, August 18th. The shares were purchased at an average cost of $4.68 per share, for a total transaction of $113,302.80. Following the completion of the acquisition, the chief executive officer now owns 277,300 shares in the company, valued at approximately $1,297,764. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Brandon M. Cruz bought 78,263 shares of GoHealth stock in a transaction on Tuesday, August 17th. The shares were acquired at an average price of $4.67 per share, for a total transaction of $365,488.21. Following the completion of the acquisition, the insider now owns 135,044 shares of the company’s stock, valued at approximately $630,655.48. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 277,300 shares of company stock valued at $1,296,981. 33.34% of the stock is owned by insiders.

Several institutional investors have recently modified their holdings of GOCO. River Road Asset Management LLC lifted its holdings in shares of GoHealth by 110.3% in the second quarter. River Road Asset Management LLC now owns 11,339,705 shares of the company’s stock valued at $127,118,000 after purchasing an additional 5,947,473 shares in the last quarter. Millennium Management LLC lifted its holdings in shares of GoHealth by 16,588.3% in the first quarter. Millennium Management LLC now owns 1,983,577 shares of the company’s stock valued at $23,188,000 after purchasing an additional 1,971,691 shares in the last quarter. BlackRock Inc. lifted its holdings in shares of GoHealth by 25.5% in the first quarter. BlackRock Inc. now owns 4,398,404 shares of the company’s stock valued at $51,416,000 after purchasing an additional 894,810 shares in the last quarter. Cannell Capital LLC lifted its holdings in shares of GoHealth by 127.7% in the first quarter. Cannell Capital LLC now owns 1,158,070 shares of the company’s stock valued at $13,538,000 after purchasing an additional 649,410 shares in the last quarter. Finally, Renaissance Technologies LLC bought a new stake in shares of GoHealth in the second quarter valued at about $5,079,000. Institutional investors own 30.88% of the company’s stock.

About GoHealth

GoHealth, Inc operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareÂInternal; MedicareÂExternal; Individual and Family Plans (IFP) and OtherÂInternal; and Individual and Family Plans and OtherÂExternal.

Featured Article: How does new data get added to a blockchain?

Analyst Recommendations for GoHealth (NASDAQ:GOCO)

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.